197 related articles for article (PubMed ID: 27364684)
21. CTCF-Mediated Chromatin Loops between Promoter and Gene Body Regulate Alternative Splicing across Individuals.
Ruiz-Velasco M; Kumar M; Lai MC; Bhat P; Solis-Pinson AB; Reyes A; Kleinsorg S; Noh KM; Gibson TJ; Zaugg JB
Cell Syst; 2017 Dec; 5(6):628-637.e6. PubMed ID: 29199022
[TBL] [Abstract][Full Text] [Related]
22. Identification of genes periodically expressed in the human cell cycle and their expression in tumors.
Whitfield ML; Sherlock G; Saldanha AJ; Murray JI; Ball CA; Alexander KE; Matese JC; Perou CM; Hurt MM; Brown PO; Botstein D
Mol Biol Cell; 2002 Jun; 13(6):1977-2000. PubMed ID: 12058064
[TBL] [Abstract][Full Text] [Related]
23. Genome-wide analysis of gene expression regulated by the HAT cofactor Trrap in conditional knockout cells.
Herceg Z; Li H; Cuenin C; Shukla V; Radolf M; Steinlein P; Wang ZQ
Nucleic Acids Res; 2003 Dec; 31(23):7011-23. PubMed ID: 14627834
[TBL] [Abstract][Full Text] [Related]
24. Competing endogenous RNA network analysis identifies critical genes among the different breast cancer subtypes.
Chen J; Xu J; Li Y; Zhang J; Chen H; Lu J; Wang Z; Zhao X; Xu K; Li Y; Li X; Zhang Y
Oncotarget; 2017 Feb; 8(6):10171-10184. PubMed ID: 28052038
[TBL] [Abstract][Full Text] [Related]
25. Landscape of expression profiles in esophageal carcinoma by The Cancer Genome Atlas data.
Zhan C; Yan L; Wang L; Jiang W; Zhang Y; Xi J; Jin Y; Chen L; Shi Y; Lin Z; Wang Q
Dis Esophagus; 2016 Nov; 29(8):920-928. PubMed ID: 26402921
[TBL] [Abstract][Full Text] [Related]
26. Identification of fibroblast growth factor-8b target genes associated with early and late cell cycle events in breast cancer cells.
Nilsson EM; Brokken LJ; Narvi E; Kallio MJ; Härkönen PL
Mol Cell Endocrinol; 2012 Jul; 358(1):104-15. PubMed ID: 22465097
[TBL] [Abstract][Full Text] [Related]
27. Cell cycle-dependent regulation of the bi-directional overlapping promoter of human BRCA2/ZAR2 genes in breast cancer cells.
Misra S; Sharma S; Agarwal A; Khedkar SV; Tripathi MK; Mittal MK; Chaudhuri G
Mol Cancer; 2010 Mar; 9():50. PubMed ID: 20202217
[TBL] [Abstract][Full Text] [Related]
28. MicroRNA expression and gene regulation drive breast cancer progression and metastasis in PyMT mice.
Nogales-Cadenas R; Cai Y; Lin JR; Zhang Q; Zhang W; Montagna C; Zhang ZD
Breast Cancer Res; 2016 Jul; 18(1):75. PubMed ID: 27449149
[TBL] [Abstract][Full Text] [Related]
29. SETD2-dependent H3K36me3 plays a critical role in epigenetic regulation of the HPV31 life cycle.
Gautam D; Johnson BA; Mac M; Moody CA
PLoS Pathog; 2018 Oct; 14(10):e1007367. PubMed ID: 30312361
[TBL] [Abstract][Full Text] [Related]
30. MDR1 promoter hypermethylation in MCF-7 human breast cancer cells: changes in chromatin structure induced by treatment with 5-Aza-cytidine.
David GL; Yegnasubramanian S; Kumar A; Marchi VL; De Marzo AM; Lin X; Nelson WG
Cancer Biol Ther; 2004 Jun; 3(6):540-8. PubMed ID: 15034303
[TBL] [Abstract][Full Text] [Related]
31. Transcription factor profiling reveals molecular choreography and key regulators of human retrotransposon expression.
Sun X; Wang X; Tang Z; Grivainis M; Kahler D; Yun C; Mita P; Fenyö D; Boeke JD
Proc Natl Acad Sci U S A; 2018 Jun; 115(24):E5526-E5535. PubMed ID: 29802231
[TBL] [Abstract][Full Text] [Related]
32. WDR5 Expression Is Prognostic of Breast Cancer Outcome.
Dai X; Guo W; Zhan C; Liu X; Bai Z; Yang Y
PLoS One; 2015; 10(9):e0124964. PubMed ID: 26355959
[TBL] [Abstract][Full Text] [Related]
33. The histone chaperone HJURP is a new independent prognostic marker for luminal A breast carcinoma.
Montes de Oca R; Gurard-Levin ZA; Berger F; Rehman H; Martel E; Corpet A; de Koning L; Vassias I; Wilson LO; Meseure D; Reyal F; Savignoni A; Asselain B; Sastre-Garau X; Almouzni G
Mol Oncol; 2015 Mar; 9(3):657-74. PubMed ID: 25497280
[TBL] [Abstract][Full Text] [Related]
34. SMYD3 encodes a histone methyltransferase involved in the proliferation of cancer cells.
Hamamoto R; Furukawa Y; Morita M; Iimura Y; Silva FP; Li M; Yagyu R; Nakamura Y
Nat Cell Biol; 2004 Aug; 6(8):731-40. PubMed ID: 15235609
[TBL] [Abstract][Full Text] [Related]
35. A New Chromatin-Cytoskeleton Link in Cancer.
Giaccia AJ
Mol Cancer Res; 2016 Dec; 14(12):1173-1175. PubMed ID: 27528705
[TBL] [Abstract][Full Text] [Related]
36. Genome-wide identification of cancer-related polyadenylated and non-polyadenylated RNAs in human breast and lung cell lines.
Zhao G; Jiao F; Liao Q; Luo H; Li H; Sun L; Bu D; Yu K; Zhao Y; Chen R
Sci China Life Sci; 2013 Jun; 56(6):503-12. PubMed ID: 23666362
[TBL] [Abstract][Full Text] [Related]
37. Cell Cycle Profiling Reveals Protein Oscillation, Phosphorylation, and Localization Dynamics.
Herr P; Boström J; Rullman E; Rudd SG; Vesterlund M; Lehtiö J; Helleday T; Maddalo G; Altun M
Mol Cell Proteomics; 2020 Apr; 19(4):608-623. PubMed ID: 32051232
[TBL] [Abstract][Full Text] [Related]
38. Expression of the Long Intergenic Non-Protein Coding RNA 665 (LINC00665) Gene and the Cell Cycle in Hepatocellular Carcinoma Using The Cancer Genome Atlas, the Gene Expression Omnibus, and Quantitative Real-Time Polymerase Chain Reaction.
Wen DY; Lin P; Pang YY; Chen G; He Y; Dang YW; Yang H
Med Sci Monit; 2018 May; 24():2786-2808. PubMed ID: 29728556
[TBL] [Abstract][Full Text] [Related]
39. Identification of Key Genes and Pathways in Cervical Cancer by Bioinformatics Analysis.
Wu X; Peng L; Zhang Y; Chen S; Lei Q; Li G; Zhang C
Int J Med Sci; 2019; 16(6):800-812. PubMed ID: 31337953
[TBL] [Abstract][Full Text] [Related]
40. Molecular Differences between Screen-Detected and Interval Breast Cancers Are Largely Explained by PAM50 Subtypes.
Li J; Ivansson E; Klevebring D; Tobin NP; Lindström LS; Holm J; Prochazka G; Cristando C; Palmgren J; Törnberg S; Humphreys K; Hartman J; Frisell J; Rantalainen M; Lindberg J; Hall P; Bergh J; Grönberg H; Czene K
Clin Cancer Res; 2017 May; 23(10):2584-2592. PubMed ID: 27587435
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
